Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 3
1980 5
1982 4
1984 4
1985 3
1986 7
1987 6
1988 6
1989 1
1990 3
1991 7
1992 3
1993 4
1994 6
1995 6
1996 4
1997 3
1998 5
1999 3
2000 6
2001 8
2002 7
2003 7
2004 4
2005 23
2006 14
2007 6
2008 10
2009 5
2010 10
2011 12
2012 15
2013 9
2014 8
2015 10
2016 4
2017 7
2018 3
2019 2
2020 4
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

233 results
Results by year
Filters applied: . Clear all
Page 1
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
Ma BBY, Lim WT, Goh BC, Hui EP, Lo KW, Pettinger A, Foster NR, Riess JW, Agulnik M, Chang AYC, Chopra A, Kish JA, Chung CH, Adkins DR, Cullen KJ, Gitlitz BJ, Lim DW, To KF, Chan KCA, Lo YMD, King AD, Erlichman C, Yin J, Costello BA, Chan ATC. Ma BBY, et al. Among authors: erlichman c. J Clin Oncol. 2018 May 10;36(14):1412-1418. doi: 10.1200/JCO.2017.77.0388. Epub 2018 Mar 27. J Clin Oncol. 2018. PMID: 29584545 Free PMC article. Clinical Trial.
Microsatellite Instability in Patients With Stage III Colon Cancer Receiving Fluoropyrimidine With or Without Oxaliplatin: An ACCENT Pooled Analysis of 12 Adjuvant Trials.
Cohen R, Taieb J, Fiskum J, Yothers G, Goldberg R, Yoshino T, Alberts S, Allegra C, de Gramont A, Seitz JF, O'Connell M, Haller D, Wolmark N, Erlichman C, Zaniboni A, Lonardi S, Kerr R, Grothey A, Sinicrope FA, André T, Shi Q. Cohen R, et al. Among authors: erlichman c. J Clin Oncol. 2021 Feb 20;39(6):642-651. doi: 10.1200/JCO.20.01600. Epub 2020 Dec 23. J Clin Oncol. 2021. PMID: 33356421
Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
McCleary-Wheeler AL, Carr RM, Palmer SR, Smyrk TC, Allred JB, Almada LL, Tolosa EJ, Lamberti MJ, Marks DL, Borad MJ, Molina JR, Qi Y, Lingle WL, Grothey A, Pitot HC, Jatoi A, Northfelt DW, Bryce AH, McWilliams RR, Okuno SH, Haluska P, Kim GP, Colon-Otero G, Lowe VJ, Callstrom MR, Ma WW, Bekaii-Saab T, Hung MC, Erlichman C, Fernandez-Zapico ME. McCleary-Wheeler AL, et al. Among authors: erlichman c. Pancreatology. 2020 Jan;20(1):101-109. doi: 10.1016/j.pan.2019.11.011. Epub 2019 Nov 21. Pancreatology. 2020. PMID: 31787526 Free PMC article. Clinical Trial.
The clinical case for proton beam therapy.
Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. Foote RL, et al. Among authors: erlichman c. Radiat Oncol. 2012 Oct 22;7:174. doi: 10.1186/1748-717X-7-174. Radiat Oncol. 2012. PMID: 23083010 Free PMC article. Review.
Targeting of the Hedgehog/GLI and mTOR pathways in advanced pancreatic cancer, a phase 1 trial of Vismodegib and Sirolimus combination.
Carr RM, Duma N, McCleary-Wheeler AL, Almada LL, Marks DL, Graham RP, Smyrk TC, Lowe V, Borad MJ, Kim G, Johnson GB, Allred JB, Yin J, Lim VS, Bekaii-Saab T, Ma WW, Erlichman C, Adjei AA, Fernandez-Zapico ME. Carr RM, et al. Among authors: erlichman c. Pancreatology. 2020 Sep;20(6):1115-1122. doi: 10.1016/j.pan.2020.06.015. Epub 2020 Jul 14. Pancreatology. 2020. PMID: 32778368
A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma.
Xie H, Yin J, Shah MH, Menefee ME, Bible KC, Reidy-Lagunes D, Kane MA, Quinn DI, Gandara DR, Erlichman C, Adjei AA. Xie H, et al. Among authors: erlichman c. Invest New Drugs. 2019 Aug;37(4):755-762. doi: 10.1007/s10637-019-00797-1. Epub 2019 Jun 6. Invest New Drugs. 2019. PMID: 31172443 Free PMC article. Clinical Trial.
An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
Bible KC, Menefee ME, Lin CJ, Millward MJ, Maples WJ, Goh BC, Karlin NJ, Kane MA, Adkins DR, Molina JR, Donehower RC, Lim WT, Flynn PJ, Richardson RL, Traynor AM, Rubin J, LoRusso PM, Smallridge RC, Burton JK, Suman VJ, Kumar A, Voss JS, Rumilla KM, Kipp BR, Chintakuntlawar AV, Harris P, Erlichman C. Bible KC, et al. Among authors: erlichman c. Thyroid. 2020 Sep;30(9):1254-1262. doi: 10.1089/thy.2019.0269. Epub 2020 Jul 29. Thyroid. 2020. PMID: 32538690
Medical management of pancreatic neuroendocrine tumors.
Delaunoit T, Neczyporenko F, Rubin J, Erlichman C, Hobday TJ. Delaunoit T, et al. Among authors: erlichman c. Am J Gastroenterol. 2008 Feb;103(2):475-83; quiz 484. doi: 10.1111/j.1572-0241.2007.01643.x. Epub 2007 Nov 19. Am J Gastroenterol. 2008. PMID: 18028508 Review.
New treatment options for colorectal cancer.
Erlichman C, Sargent DJ. Erlichman C, et al. N Engl J Med. 2004 Jul 22;351(4):391-2. doi: 10.1056/NEJMe048151. N Engl J Med. 2004. PMID: 15269321 No abstract available.
Oxaliplatin in the treatment of colorectal cancer.
Kim GP, Erlichman C. Kim GP, et al. Among authors: erlichman c. Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):281-94. doi: 10.1517/17425255.3.2.281. Expert Opin Drug Metab Toxicol. 2007. PMID: 17428157 Review.
233 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page